News und Analysen
DGAP-News: MicroVision to Participate in Upcoming Investor Conferences
Simulations Plus Successfully Delivers FDA-Funded Project
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical and biotechnology industries, today announced the completion of a newly funded
MD Medical Group Investments Plc: Results of the Annual General Meeting of Shareholders
MD Medical Group Investments Plc: MDMG reports 8% growth in Revenue in Q1 2022
DGAP-News: MicroVision Announces First Quarter 2022 Results
DGAP-News: MicroVision Releases Videos of Track Testing for Ground-Truth Data
DGAP-Adhoc: 2021 financial figures of Vita 34 AG expected to be significantly below market expectations due to several special effects on earnings development
Annual General Meeting - Shareholders approve all proposals of the Board of Directors
Simulations Plus Enters New Collaboration to Advance DDDPlus™ Software
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced a new
DGAP-News: MicroVision Inc.: MicroVision to Announce First Quarter 2022 Results on April 27, 2022
STAAR Surgical to Report First Quarter Results on May 4, 2022
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release
Simulations Plus to Present at the Berenberg Discover AI Seminar
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that management will be
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Vorläufige Zahlen für das 1. Quartal 2022 - Zunehmende Schwierigkeiten bei der Lieferung elektronischer Bauteile machen das untere Ende der Jahresprognose wahrscheinlich
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures for the first quarter of 2022 - Increasing difficulties in the supply of electronic components make the lower end of the full-year guidance likely
NanoString Highlights Spatial Biology Research at the 2022 American Association of Cancer Research (AACR) Conference
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the highlights of over 125 studies enabled by
DGAP-HV: STRATEC SE: Bekanntmachung der Einberufung zur Hauptversammlung am 20.05.2022 in Virtuelle Hauptversammlung mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
AEVIS VICTORIA SA - Ordinary General Meeting of Shareholders on 28 April 2022
AEVIS VICTORIA SA - Ordentliche Generalversammlung vom 28. April 2022
Simulations Plus Reports Second Quarter Fiscal 2022 Financial Results
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today reported financial results for its second
AEVIS VICTORIA SA erzielte im Jahr 2021 ein sehr gutes Ergebnis mit ihren Beteiligungen, bei einem Ertrag von CHF 216.4 Millionen und einem Reingewinn von CHF 197.6 Millionen auf Holdingebene
AEVIS VICTORIA SA achieved very strong results on its investments in 2021 with a holding income of CHF 216.4 million and a net profit of CHF 197.6 million
DGAP-News: STRATEC SE: STRATEC ERZIELT IM GESCHÄFTSJAHR 2021 NEUE REKORDWERTE BEI UMSATZ UND ERGEBNIS
DGAP-News: STRATEC SE: STRATEC GENERATES NEW RECORD SALES AND EARNINGS IN 2021 FINANCIAL YEAR
Simulations Plus Receives $1.7 Million Grant for BIOLOGXsym™ Macromolecule Safety Software
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it has received a Phase II